SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER is a Topical Emulsion in the Human Otc Drug category. It is labeled and distributed by Shiseido Americas Corporation. The primary component is Titanium Dioxide; Octinoxate; Ensulizole.
Product ID | 58411-657_5372d970-e30f-48ff-b10f-2b2f74dfccc9 |
NDC | 58411-657 |
Product Type | Human Otc Drug |
Proprietary Name | SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER |
Generic Name | Titanium Dioxide, Octinoxate, And Ensulizole |
Dosage Form | Emulsion |
Route of Administration | TOPICAL |
Marketing Start Date | 2021-05-01 |
Marketing Category | OTC MONOGRAPH NOT FINAL / |
Application Number | part352 |
Labeler Name | SHISEIDO AMERICAS CORPORATION |
Substance Name | TITANIUM DIOXIDE; OCTINOXATE; ENSULIZOLE |
Active Ingredient Strength | 2 g/40mL; g/40mL; g/40mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |